The effect of endotoxin on 1,2-dimethylhydrazine-induced colonic tumors in rats.
The effect of endotoxin on colon tumors was studied in male Sprague-Dawley rats. Colon tumors were induced in weanling rats by the administration of 20 weekly subcutaneous injections of 1,2-dimethylhydrazine (DMH). When colon tumors were detected by colonoscopy in 80% of the rats around week 24 after DMH injection, the animals were divided randomly into two groups. One group served as the control. The other group received six endotoxin (Escherichia coli) treatments every fifth day. The first dose was 50 micrograms/100 g (intraperitoneally); the remaining doses were 100 micrograms/100 g (subcutaneously). Rats were killed 2 weeks after the last endotoxin injection. Endotoxin treatments resulted in larger colon tumors. The median tumor size was 71 mm2 for endotoxin-treated and 31 mm2 for untreated rats (P less than 0.02). Endotoxin treatments also resulted in a significantly higher incidence (P less than 0.05) of ulcer development in the small intestine, that is 47% in the endotoxin-treated versus 23% in the untreated rats. After a single subcutaneous injection of endotoxin (100 micrograms/100 g), the colon mucosal reduced glutathione (GSH) level was raised by 21% at 16 hours, reached a peak on day 2, then decreased to baseline by day 4. The increased GSH level in the colon mucosa was maintained up to the third endotoxin injection. By the fifth injection, no increase in the GSH level was observed. These results suggest that the growth of colon tumors in rats induced by DMH could be enhanced by endotoxin treatments. The enhanced tumor growth may be due to an increase in the colon GSH level and/or other mediators released by macrophages as a result of endotoxin treatments.
Chen
M F
MF
Department of Internal Medicine, University of South Florida College of Medicine, Tampa 33612-4799.
Chen
L T
LT
Boyce
H W
HW
D019813:1,2-Dimethylhydrazine; D000818:Animals; D002273:Carcinogens; D003043:Cocarcinogenesis; D003106:Colon / Q000032:analysis / Q000201:enzymology; D003110:Colonic Neoplasms / Q000139:chemically induced* / Q000201:enzymology / Q000473:pathology; D004127:Dimethylhydrazines / Q000009:adverse effects*; D004731:Endotoxins / Q000008:administration & dosage / Q000494:pharmacology*; D004926:Escherichia coli; D005978:Glutathione / Q000032:analysis; D007274:Injections, Intraperitoneal; D007279:Injections, Subcutaneous; D007413:Intestinal Mucosa / Q000032:analysis / Q000201:enzymology; D008297:Male; D008763:Methylhydrazines / Q000009:adverse effects*; D011897:Random Allocation; D051381:Rats; D011919:Rats, Inbred Strains; D005723:gamma-Glutamyltransferase / Q000032:analysis
D002273:Carcinogens; D004127:Dimethylhydrazines; D004731:Endotoxins; D008763:Methylhydrazines; D005723:gamma-Glutamyltransferase; D005978:Glutathione; D019813:1,2-Dimethylhydrazine